| Wendla K Citron, MD | |
|
305 Hospital Dr, Tate Cancer Center, Glen Burnie, MD 21061-5805 | |
| (410) 553-8100 | |
| Not Available |
| Full Name | Wendla K Citron |
|---|---|
| Gender | Female |
| Speciality | Radiation Oncology |
| Experience | 23 Years |
| Location | 305 Hospital Dr, Glen Burnie, Maryland |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1477588846 | NPI | - | NPPES |
| 410289400 | Medicaid | MD | |
| P00405542 | Other | MD | RAILROAD MEDICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0001X | Radiology - Radiation Oncology | D0063808 (Maryland) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| University Of Md Baltimore Washington Medical Center | Glen burnie, MD | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Of Maryland Radiation Oncology Associates Pa | 6406845544 | 29 |
News Archive
Biovest International, Inc., a majority-owned subsidiary of Accentia Biopharmaceuticals, Inc., today announced that Biovest plans to file for marketing approval in the European Union (EU) for BiovaxID, its personalized cancer vaccine for the treatment of follicular non-Hodgkin's lymphoma, an incurable cancer of the immune system.
The first randomized, placebo-controlled U.S. clinical trial to assess the use of bone marrow-derived mononuclear cells (BMC) in patients after a ST-elevation myocardial infarction (STEMI; severe heart attack) demonstrated a strong safety profile for this cell therapy, based on phase 1 results published in the September issue of the American Heart Journal.
The nation's largest health insurance company, United Healthcare, launched a new push this week to get employees to directly lobby U.S. Senators for weaker health reform and higher insurer profits. The new campaign, in an e-mail sent to all employees Nov. 10, offers employees template letters to send from company computers on company time and urges them to write grassroots-style letters to the editor to local newspapers. Consumer Watchdog, which obtained the letters, called on the Senate and newspapers to reject this deceptive corporate-directed campaign.
One in five Americans are completely unaware that they are at risk for the second leading cause of premature death: high blood pressure. In the first ever analysis of awareness, treatment, and control of hypertension for every county, the Institute for Health Metrics and Evaluation at the University of Washington revealed significant differences across the US.
Porous polymer scaffolds fabricated to support the growth of biological tissue for implantation may hold the potential to greatly accelerate the development of cancer therapeutics.
› Verified 5 days ago
| Entity Name | University Of Maryland Community Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477530624 PECOS PAC ID: 3678472214 Enrollment ID: O20040102000687 |
News Archive
Biovest International, Inc., a majority-owned subsidiary of Accentia Biopharmaceuticals, Inc., today announced that Biovest plans to file for marketing approval in the European Union (EU) for BiovaxID, its personalized cancer vaccine for the treatment of follicular non-Hodgkin's lymphoma, an incurable cancer of the immune system.
The first randomized, placebo-controlled U.S. clinical trial to assess the use of bone marrow-derived mononuclear cells (BMC) in patients after a ST-elevation myocardial infarction (STEMI; severe heart attack) demonstrated a strong safety profile for this cell therapy, based on phase 1 results published in the September issue of the American Heart Journal.
The nation's largest health insurance company, United Healthcare, launched a new push this week to get employees to directly lobby U.S. Senators for weaker health reform and higher insurer profits. The new campaign, in an e-mail sent to all employees Nov. 10, offers employees template letters to send from company computers on company time and urges them to write grassroots-style letters to the editor to local newspapers. Consumer Watchdog, which obtained the letters, called on the Senate and newspapers to reject this deceptive corporate-directed campaign.
One in five Americans are completely unaware that they are at risk for the second leading cause of premature death: high blood pressure. In the first ever analysis of awareness, treatment, and control of hypertension for every county, the Institute for Health Metrics and Evaluation at the University of Washington revealed significant differences across the US.
Porous polymer scaffolds fabricated to support the growth of biological tissue for implantation may hold the potential to greatly accelerate the development of cancer therapeutics.
› Verified 5 days ago
| Entity Name | Baltimore Washington Medical Center Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1124016696 PECOS PAC ID: 7719879485 Enrollment ID: O20040326001160 |
News Archive
Biovest International, Inc., a majority-owned subsidiary of Accentia Biopharmaceuticals, Inc., today announced that Biovest plans to file for marketing approval in the European Union (EU) for BiovaxID, its personalized cancer vaccine for the treatment of follicular non-Hodgkin's lymphoma, an incurable cancer of the immune system.
The first randomized, placebo-controlled U.S. clinical trial to assess the use of bone marrow-derived mononuclear cells (BMC) in patients after a ST-elevation myocardial infarction (STEMI; severe heart attack) demonstrated a strong safety profile for this cell therapy, based on phase 1 results published in the September issue of the American Heart Journal.
The nation's largest health insurance company, United Healthcare, launched a new push this week to get employees to directly lobby U.S. Senators for weaker health reform and higher insurer profits. The new campaign, in an e-mail sent to all employees Nov. 10, offers employees template letters to send from company computers on company time and urges them to write grassroots-style letters to the editor to local newspapers. Consumer Watchdog, which obtained the letters, called on the Senate and newspapers to reject this deceptive corporate-directed campaign.
One in five Americans are completely unaware that they are at risk for the second leading cause of premature death: high blood pressure. In the first ever analysis of awareness, treatment, and control of hypertension for every county, the Institute for Health Metrics and Evaluation at the University of Washington revealed significant differences across the US.
Porous polymer scaffolds fabricated to support the growth of biological tissue for implantation may hold the potential to greatly accelerate the development of cancer therapeutics.
› Verified 5 days ago
| Entity Name | University Of Maryland Radiation Oncology Associates Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1780637272 PECOS PAC ID: 6406845544 Enrollment ID: O20040512000493 |
News Archive
Biovest International, Inc., a majority-owned subsidiary of Accentia Biopharmaceuticals, Inc., today announced that Biovest plans to file for marketing approval in the European Union (EU) for BiovaxID, its personalized cancer vaccine for the treatment of follicular non-Hodgkin's lymphoma, an incurable cancer of the immune system.
The first randomized, placebo-controlled U.S. clinical trial to assess the use of bone marrow-derived mononuclear cells (BMC) in patients after a ST-elevation myocardial infarction (STEMI; severe heart attack) demonstrated a strong safety profile for this cell therapy, based on phase 1 results published in the September issue of the American Heart Journal.
The nation's largest health insurance company, United Healthcare, launched a new push this week to get employees to directly lobby U.S. Senators for weaker health reform and higher insurer profits. The new campaign, in an e-mail sent to all employees Nov. 10, offers employees template letters to send from company computers on company time and urges them to write grassroots-style letters to the editor to local newspapers. Consumer Watchdog, which obtained the letters, called on the Senate and newspapers to reject this deceptive corporate-directed campaign.
One in five Americans are completely unaware that they are at risk for the second leading cause of premature death: high blood pressure. In the first ever analysis of awareness, treatment, and control of hypertension for every county, the Institute for Health Metrics and Evaluation at the University of Washington revealed significant differences across the US.
Porous polymer scaffolds fabricated to support the growth of biological tissue for implantation may hold the potential to greatly accelerate the development of cancer therapeutics.
› Verified 5 days ago
| Entity Name | Maryland Proton Treatment Center, Llc |
|---|---|
| Entity Type | Part B Supplier - Radiation Therapy Center |
| Entity Identifiers | NPI Number: 1255742375 PECOS PAC ID: 5597070524 Enrollment ID: O20150819008188 |
News Archive
Biovest International, Inc., a majority-owned subsidiary of Accentia Biopharmaceuticals, Inc., today announced that Biovest plans to file for marketing approval in the European Union (EU) for BiovaxID, its personalized cancer vaccine for the treatment of follicular non-Hodgkin's lymphoma, an incurable cancer of the immune system.
The first randomized, placebo-controlled U.S. clinical trial to assess the use of bone marrow-derived mononuclear cells (BMC) in patients after a ST-elevation myocardial infarction (STEMI; severe heart attack) demonstrated a strong safety profile for this cell therapy, based on phase 1 results published in the September issue of the American Heart Journal.
The nation's largest health insurance company, United Healthcare, launched a new push this week to get employees to directly lobby U.S. Senators for weaker health reform and higher insurer profits. The new campaign, in an e-mail sent to all employees Nov. 10, offers employees template letters to send from company computers on company time and urges them to write grassroots-style letters to the editor to local newspapers. Consumer Watchdog, which obtained the letters, called on the Senate and newspapers to reject this deceptive corporate-directed campaign.
One in five Americans are completely unaware that they are at risk for the second leading cause of premature death: high blood pressure. In the first ever analysis of awareness, treatment, and control of hypertension for every county, the Institute for Health Metrics and Evaluation at the University of Washington revealed significant differences across the US.
Porous polymer scaffolds fabricated to support the growth of biological tissue for implantation may hold the potential to greatly accelerate the development of cancer therapeutics.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Wendla K Citron, MD 305 Hospital Drive, Tate Cancer Center, Glen Burnie, MD 21061 Ph: (410) 553-8100 | Wendla K Citron, MD 305 Hospital Dr, Tate Cancer Center, Glen Burnie, MD 21061-5805 Ph: (410) 553-8100 |
News Archive
Biovest International, Inc., a majority-owned subsidiary of Accentia Biopharmaceuticals, Inc., today announced that Biovest plans to file for marketing approval in the European Union (EU) for BiovaxID, its personalized cancer vaccine for the treatment of follicular non-Hodgkin's lymphoma, an incurable cancer of the immune system.
The first randomized, placebo-controlled U.S. clinical trial to assess the use of bone marrow-derived mononuclear cells (BMC) in patients after a ST-elevation myocardial infarction (STEMI; severe heart attack) demonstrated a strong safety profile for this cell therapy, based on phase 1 results published in the September issue of the American Heart Journal.
The nation's largest health insurance company, United Healthcare, launched a new push this week to get employees to directly lobby U.S. Senators for weaker health reform and higher insurer profits. The new campaign, in an e-mail sent to all employees Nov. 10, offers employees template letters to send from company computers on company time and urges them to write grassroots-style letters to the editor to local newspapers. Consumer Watchdog, which obtained the letters, called on the Senate and newspapers to reject this deceptive corporate-directed campaign.
One in five Americans are completely unaware that they are at risk for the second leading cause of premature death: high blood pressure. In the first ever analysis of awareness, treatment, and control of hypertension for every county, the Institute for Health Metrics and Evaluation at the University of Washington revealed significant differences across the US.
Porous polymer scaffolds fabricated to support the growth of biological tissue for implantation may hold the potential to greatly accelerate the development of cancer therapeutics.
› Verified 5 days ago
Oluwaseun Babalola, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 1600 Crain Hwy S Ste 101, Glen Burnie, MD 21061 Phone: 410-918-3200 Fax: 410-918-3425 | |
Marshall Kyle Mills, Radiology Medicare: Not Enrolled in Medicare Practice Location: 301 Hospital Dr, Glen Burnie, MD 21061 Phone: 410-787-4000 | |
Dr. Dorothy Boo, M.D. Radiology Medicare: Not Enrolled in Medicare Practice Location: 305 Hospital Dr, Glen Burnie, MD 21061 Phone: 410-553-8100 | |
Akshar Nareshroy Patel, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 305 Hospital Dr, Glen Burnie, MD 21061 Phone: 410-553-8100 Fax: 410-706-6729 |